Skip to main content
. 2014 Jul 30;34(31):10285–10297. doi: 10.1523/JNEUROSCI.4915-13.2014

Figure 2.

Figure 2.

Axin2 immunoreactivity in control and KO mice. A, Anti-axin2 staining of wild-type uninjured thoracic spinal cord, injured control, and injured KO spinal cord at 5 dpl. Scale bar, 50 μm. B, Axin2 immunoreactivity in uninjured control and KO YFP-positive OPCs. Axin2 immunoreactivity is reduced in OPCs in the β-catenin KO mice. Scale bar, 10 μm. C, Axin2 immunoreactivity in YFP+ cells at 5 dpl in injured control and KO animals. Scale bar, 10 μm. D, Anti-NG2 and anti-axin2 staining of 5 dpl injured spinal cord in control and KO mice. Scale bar, 15 μm. Knocking out β-catenin in OPCs reduces axin2 expression throughout the spinal cord and in both the YFP+ and NG2+ cell populations.